Trial Profile
A Phase I Study Of Medi 522 In Patients With Advanced Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2019
Price :
$35
*
At a glance
- Drugs Etaracizumab (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 24 Sep 2005 New trial record.